This is a preview of subscription content, log in via an institution to check access.
Notes
funded by GlaxoSmithKline Biologicals SA
Reference
Simons JJM, et al. Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands. Vaccine : 22 May 2020. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2020.05.031
Rights and permissions
About this article
Cite this article
Inclusion of boys for HPV vaccination cost effective in the Netherlands. PharmacoEcon Outcomes News 855, 20 (2020). https://doi.org/10.1007/s40274-020-6885-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6885-3